Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The release of dopamine in the brain plays a key role in determining how we respond when we perceive a potential reward or benefit. But so far little has been understood about the mechanism behind this. A new paper from Department of Physiology, Anatomy & Genetics has uncovered a dominant regulator of the dynamics of dopamine output.

None

Dopamine in the striatum of the brain is critical to the selection and learning of our motivated actions. Dopamine neurons input into a system called the basal ganglia which regulates our voluntary actions and helps us to respond particularly to something we perceive as having a benefit or rewarding property, and consequently carrying motivational value. Dopamine helps us select actions and learn from the associations we make between a stimulus, our action and its outcome, to change the way we might respond next time.

A new paper from Department of Physiology, Anatomy & Genetics (DPAG), published in Nature Communications, has managed to uncover some surprising observations on this unusual neuronal network. Unlike for many other types of synapses in the brain, the team has found that the short-term plasticity in dopamine release is not very sensitive to calcium and initial release probability. Instead, it shows a form of release-insensitive depression. By detecting dopamine and imaging calcium in axons, results suggest that the critical mechanisms are those that shape the ability to depolarise or repolarise axons.

Read more (DPAG website)

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.